Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02278055 · COMPLETED

Trial details

NCT number: NCT02278055
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Pain

Start date: 2014-10-08
Primary completion: 2022-02-02
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.